Folic acid supplementation doesn't boost cancer risk, analysis finds

01/28/2013 | Reuters

An examination of 13 trials involving nearly 50,000 individuals found no significant difference in the incidence of cancer between those who received folic acid supplements for five years and those who took placebos. Folic acid was not associated with a greater likelihood of developing certain types of cancer, either, including cancers of the colon, prostate, lung or breast. The findings were published in The Lancet.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN